⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16177833 | 0.81 | MMP1 (0.36) | — | |
| SCHEMBL3486881 | 0.78 | — | — | |
| Hydrochloric Acid SCHEMBL28132101 | 0.75 | — | — | |
| SCHEMBL8633128 | 0.75 | CA2 (0.33) | — | |
| SCHEMBL42677 | 0.75 | TP53 (0.38) | — | |
| SCHEMBL42674 | 0.75 | TP53 (0.38) | — | |
| SCHEMBL72230 | 0.75 | ACE (0.48) | — | |
| SCHEMBL72229 | 0.75 | ACE (0.48) | — | |
| SCHEMBL9392111 | 0.73 | — | — | |
| SCHEMBL9395461 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| CN-105755485-A | Novel water soluble metal pickling corrosion inhibitor and application thereof | 四川理工学院 | 2016-07-13 | — | — | CN | claimed |
| US-20100292294-A1 | Compositions Comprising a Physiological Coolant | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2010-11-18 | — | — | US | claimed |
| EP-2134319-A2 | COMPOSITIONS COMPRISING A PHYSIOLOGICAL COOLANT | Givaudan Nederland Services B.V. (NL) | 2009-12-23 | — | — | EP | claimed |
| WO-2008107137-A2 | COMPOSITIONS COMPRISING A PHYSIOLOGICAL COOLANT | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2008-09-12 | — | — | WO | claimed |
| EP-1361872-A4 | NOVEL LYSOPHOSPHATIDIC ACID RECEPTOR AGONISTS AND ANTAGONISTS | UNIV VIRGINIA (US) | 2004-05-19 | — | — | EP | claimed |
| EP-1361872-A2 | NOVEL LYSOPHOSPHATIDIC ACID RECEPTOR AGONISTS AND ANTAGONISTS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2003-11-19 | — | — | EP | claimed |
| WO-2002029001-A2 | NOVEL LYSOPHOSPHATIDIC ACID RECEPTOR AGONISTS AND ANTAGONISTS | UNIVERSITY OF VIRGINIAN PATENT FOUNDATION (US) | 2002-04-11 | — | — | WO | claimed |
| EP-0730860-B1 | Mixed micelles | HOFFMANN LA ROCHE (CH) | 2002-01-02 | — | — | EP | claimed |
| EP-0730860-A2 | Mixed micelles | F. HOFFMANN-LA ROCHE AG (CH) | 1996-09-11 | — | — | EP | claimed |
| US-20240010984-A1 | SERUM-FREE MEDIUM FOR DIFFERENTIATION OF A PROGENITOR CELL | Mosa Meat B.V. (NL) | 2024-01-11 | — | — | US | disclosed |
| EP-4251740-A1 | SERUM-FREE MEDIUM FOR DIFFERENTIATION OF A PROGENITOR CELL | Mosa Meat B.V. (NL) | 2023-10-04 | — | — | EP | disclosed |
| CN-116685676-A | Serum-free medium for progenitor cell differentiation | 莫萨米特有限公司 | 2023-09-01 | — | — | CN | disclosed |
| WO-2023003471-A1 | METHOD FOR PRODUCING CULTURED FAT FOR ANIMAL CONSUMPTION. | Mosa Meat B.V. (NL) | 2023-01-26 | — | — | WO | disclosed |
| WO-2022114955-A1 | SERUM-FREE MEDIUM FOR DIFFERENTIATION OF A PROGENITOR CELL | Mosa Meat B.V. (NL) | 2022-06-02 | — | — | WO | disclosed |
| US-20040147562-A1 | Methods of treating conditions associated with an EDG-1 receptor | MANIV ENERGY CAPITAL | 2004-07-29 | — | — | US | disclosed |
| WO-2004053459-A2 | COMPOUNDS AND MEHTODS OF USE THEREOF FOR ASSAYING LYSOPHOSPHOLIPASE D ACTIVITY | ECHELON BIOSCIENCES INCORPORATED (US) | 2004-06-24 | — | — | WO | disclosed |
| US-20040122236-A1 | Novel lysophosphatidic acid receptor agonists and antagonists | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2004-06-24 | — | — | US | disclosed |
| WO-2004009816-A1 | METHODS OF TREATING CONDITIONS ASSOCIATED WITH AN EDG-1 RECEPTOR | CERETEK LLC (US) | 2004-01-29 | — | — | WO | disclosed |
| WO-2003062392-A2 | METHODS OF TREATING CONDITIONS ASSOCIATED WITH AN EDG RECEPTOR | CERETEK LLC (US) | 2003-07-31 | — | — | WO | disclosed |